Pharmaceutical Tolmetin Base from Japan
Tolmetin base in pharmaceutical grade for conversion to salts or direct use in veterinary anti-inflammatory drugs affecting CNS pain pathways. Explicitly covered under HTS 2933.99.5510 as an aromatic modified NSAID drug. Bulk powder for API synthesis.
Duty Rate — Japan → United States
21%
Rate breakdown
9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• For veterinary use, note AVMA guidelines in docs; provide batch-specific stability data; declare as 'not for human use' if applicable to avoid FDA scrutiny